SEC Form 4 · accession 0001061983-19-000005
CYTOKINETICS INC · CYTK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward M. Kaye M.D.
Director
Period of report
Jan 2, 2019
Accepted (ET)
Jan 4, 2019 · 6:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061983
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $6.82 | Jan 2, 2019 | A | 6,414 | A | — | Jan 2, 2029 | Common Stock | 6,414 | 6,414 | D |
Explanation of responses
- F1This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on January 2, 2020.